Emergence of novel Streptococcus iniae exopolysaccharide-producing strains following vaccination with nonproducing strains

Applied and Environmental Microbiology

Volumn 74, Issue 22, 2008, Pages 6892-6897

  Eyngor, Marina ^a   Tekoah, Yoram ^b   Shapira, Roni ^a   Hurvitz, Avshalom ^c   Zlotkin, Amir ^d   Lublin, Avishay ^e   Eldar, Avi ^e  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Dan Fish Farms   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e KIMRON VETERINARY INSTITUTE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FISHERIES; MEATS;

DISEASE OUTBREAKS; EVOLUTIONARY SELECTIONS; EXO POLYSACCHARIDES; EXTRACELLULAR POLYSACCHARIDES; FATAL DISEASES; FISH POPULATIONS; FISH SPECIES; ONCORHYNCHUS MYKISS; RAINBOW TROUTS;

POLYSACCHARIDES;

EXOPOLYSACCHARIDE;

BACTERIAL DISEASE; BACTERIUM; DISEASE SPREAD; EMERGENCE; POLYSACCHARIDE; SALMONID; VACCINATION;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BRAIN; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FISH; FISH DISEASE; MORTALITY; NONHUMAN; RAINBOW TROUT; STRAIN IDENTIFICATION; STREPTOCOCCUS INIAE; SURVIVAL RATE; VACCINATION;

ANIMALS; FISH DISEASES; ONCORHYNCHUS MYKISS; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS;

ONCORHYNCHUS MYKISS; STREPTOCOCCUS INIAE;

EID: 55949120560     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00853-08     Document Type: Article

References (42)

1. Albersheim, P., D. J. Nevins, P. D. English, and A. Karr. 1967. A method for the analysis of sugars in plant cell-wall polysaccharides by gas-liquid chromatography. Carbohydr. Res. 5:340-345.
2. Alonso De Velasco, E., B. A. T. Dekker, A. F. M. Verheul, R. G. Feldman, J. Verhoef, and H. Snippe. 1995. Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice. J. Infect. Dis. 172:562-565.
3. Austrian, R. 1999. The pneumococcus at the millennium: not down, not out. J. Infect. Dis. 179(Suppl. 2):S338-S441.
4. Bachrach, G., A. Zlotkin, A. Hurvitz, D. L. Evans, and A. Eldar. 2001. Recovery of Streptococcus iniae from diseased fish previously vaccinated with a Streptococcus vaccine. Appl. Environ. Microbiol. 67:3756-3758.
5. Baker, C. J., and M. S. Edwards. 1995. Group B streptococci infections, p. 980-1054. In J. S. Remington and J. O. Klein (ed.), Infectious disease of the fetus and newborn infant, 4th ed. The W. B. Saunders Co., Philadelphia, PA.
6. Broadbent, J. R., D. J. McMahon, D. L. Welker, C. J. Oberg, and S. Moineau. 2003. Biochemistry, genetics and applications of exopolysaccharide production in Streptococcus thermophilus: a review. J. Dairy Sci. 86:407-423.
7. Cerning, J. 1990. Exocellular polysaccharides produced by lactic acid bacteria. FEMS Microbiol. Rev. 87:113-130.
8. Cerning, J. 1994. Polysaccharides exocellulaires produits par les bacteries lactiques, p. 309-329. In H. de Rossartand and F. M. Luquet (ed.), Bacteries lactiques, vol. I. Lorica, Uriage, France.
9. Dale, J. B., and S. T. Shulman. 2002. Dynamic epidemiology of group A streptococcal serotypes. Lancet 359:889.
10. De Vuyst, L., and B. Degeest. 1999. Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol. Rev. 23:153-177.
11. Doran, T. I., D. C. Straus, and S. J. Mattingly. 1981. Factors influencing release of type III antigens by group B streptococci. Infect. Immun. 31:615-623.
12. Eldar, A., S. Lawhon, P. F. Frelier, L. Asanta, B. R. Simpson, P. W. Varner, and H. Bercovier. 1997. DNA restriction length polymorphisms of 16S rRNA and of whole rRNA genes (ribotyping) of S. iniae isolates from the United States and Israel. FEMS Microbiol. Lett. 151:155-162.
13. Eldar, A., A. Hurwitz, and H. Bercovier. 1997. Development and efficacy of a streptococcal vaccine for the Israeli trout farming. Vet. Immunol. Immunopathol. 56:175-183.
14. Eskola, J., T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, E. Herva, A. Takala, H. Kayhty, P. Karma, R. Kohberger, G. Siber, P. H. Makela, et al. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344:403-409.
15. Fuller, J. D., J. B. Darrin, V. Nizet, D. E. Low, and J. C. S. de Azavedo. 2001. Streptococcus iniae virulence is associated with a distinct genetic profile. Infect. Immun. 69:1994-2000.
16. Gor, D. O., X. Ding, D. E. Briles, M. R. Jacobs, and N. S. Greenspan. 2005. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Infect. Immun. 73:1304-1312.
17. Gotschlich, E. C. 1975. Development of polysaccharide vaccines for the prevention of meningococcal diseases. Monogr. Allergy 9:245-258.
18. Henrichsen, J. 1995. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33:2759-2762.
19. Huebner, J., Y. Wang, W. A. Krueger, L. C. Madoff, G. Martirosian, S. Boisot, D. A. Goldmann, D. L. Kasper, A. O. Tzianabos, and G. B. Pier. 1999. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect. Immun. 67:1213-1219.
20. Jennings, H. J., C. Lugowski, and D. L. Kasper. 1981. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry 20:4511-4518.
21. Kaplan, E. L., J. T. Wotton, and D. R. Johnson. 2001. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet 358:1334-1337.
22. Leriche, V., P. Sibille, and B. Carpenter. 2000. Use of an enzyme-linked lectinsorbent assay to monitor the shift in polysaccharide composition in bacterial biofilms. Appl. Environ. Microbiol. 66:1851-1856.
23. Locke, J. B., K. M. Colvin, A. K. Datta, S. K. Patel, N. N. Naidu, M. N. Neely, V. Nizet, and V. T. Buchanan. 2007. Streptococcus iniae capsule impairs phagocytic clearance and contributes to virulence in fish. J. Bacteriol. 189:1279-1287.
24. Locke, J. B., R. K. Aziz, M. R. Vicknair, V. Nizet, and J. T. Buchanan. 2008. Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development. PLoS ONE 3:e2824.
25. Lowe, B. A., J. D. Miller, and M. N. Neely. 2006. Analysis of the polysaccharide capsule of the systemic pathogen Streptococcus iniae and its implications in virulence. Infect. Immun. 75:1255-1264.
26. Malley, R., K. Trzinski, A. Srivatava, C. M. Thompson, P. W. Anderson, and M. Lipsitch. 2005. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. USA 29:4848-4853.
27. Mbelle, N., R. E. Huebner, A. D. Wasas, A. Kimura, I. Chang, and K. P. Klugman. 1999. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180:1171-1176.
28. Mozzi, F., F. Vaningelgem, E. M. Hébert, R. Van der Meulen, M. Remedios Foulquié Moreno, G. Font de Valdez, and L. De Vuyst. 2006. Diversity of heteropolysaccharide-producing lactic acid bacterium strains and their biopolymers. Appl. Environ. Microbiol. 72:4431-4435.
29. Nakasone, C., N. Yamamoto, M. Nakamatsu, T. Kinjo, K. Miyagi, K. Uezu, K. Nakamura, F. Higa, H. Ishikawa, R. L. O'Brien, K. Ikuta, M. Kaku, J. Fujita, and K. Kawakami. 2007. Accumulation of gamma/delta T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection. Microbes Infect. 9:251-258.
30. Robbins, J. J. B., R. R. Austrian, C. C. J. Lee, S. S. C. Rastogi, G. G. Schiffman, J. J. Henrichsen, P. P. H. Makela, C. C. V. Broome, R. R. R. Facklam, and R. R. H. Tiesjema. 1983. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J. Infect. Dis. 148:1136-1159.
31. Rubens, C. E., M. R. Wessels, L. M. Heggen, and D. L. Kasper. 1987. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc. Natl. Acad. Sci. USA 84:7208-7212.
32. Smit, P., D. Oberholzer, S. Hayden-Smith, H. J. Koornhof, and M. R. Hilleman. 1977. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 238:2613-2616.
33. Stingele, F., J. R. Neeser, and B. Mollet. 1996. Identification and characterization of the eps (exopolysaccharide) gene cluster from Streptococcus thermophilus Sfi6. J. Bacteriol. 178:1680-1690.
34. Takahashi, S., E. E. Adderson, Y. Nagano, N. Nagano, M. R. Briesacher, and J. F. Bohnsack. 1998. Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J. Infect. Dis. 177:1116-1119.
35. Taylor, C. E., and R. Bright. 1989. T-cell modulation of the antibody response to bacterial polysaccharide antigens. Infect. Immun. 57:180-185.
36. Thomas, V. L., B. A. Sanford, R. Moreno, and M. A. Ramsay. 1997. Enzyme-linked lectinsorbent assay measures N-acetyl-D-glucosamine in matrix of biofilm produced by Staphylococcus epidermidis. Curr. Microbiol. 35:249-254.
37. Thompson, H. C., and T. K. Eisenstein. 1976. Biological properties of an immunogenic pneumococcal subcellular preparation. Infect. Immun. 13:750-757.
38. Vaningelgem, F., M. Zamfir, F. Mozzi, T. Adriany, M. Vancanneyt, J. Swings, and L. De Vuyst. 2004. Biodiversity of exopolysaccharides produced by Streptococcus thermophilus strains is reflected in their production and their molecular and functional characteristics. Appl. Environ. Microbiol. 70:900-912.
39. Weinstein, M. R., M. Litt, D. A. Kertesz, P. Wyper, D. Rose, M. Coulter, A. McGeer, R. Facklam, C. Ostach, B. M. Willey, A. Borczyk, and D. E. Low for the S. iniae Study Group. 1997. Invasive infections due to a fish pathogen, Streptococcus iniae. N. Engl. J. Med. 337:589-594.
40. Wisselink, H. J., N. Stockhofe-Zurwieden, L. A. T. Hilgers, and H. E. Smith. 2002. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2. Vet. Microbiol. 84:155-168.
41. Zlotkin, A., H. Hershko, and A. Eldar. 1998. Possible transmission of Streptococcus iniae to cultured fish. Appl. Environ. Microbiol. 64:4065-4067.
42. Zlotkin, A., S. Chilmonczyk, M. Ingor, A. Hurvitz, C. Ghittino, and A. Eldar. 2003. Trojan horse effect: phagocyte-mediated Streptococcus iniae infection of fish. Infect. Immun. 71:2318-2325.